Papers: 12 Sep 2014 - 19 Sep 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Clinical and MRI characterization of MS patients with a pure and severe cognitive onset. Assouad R, Louapre C, Tourbah A, Papeix C, Galanaud D, Lubetzki C, Stankoff B Clin Neurol Neurosurg. 2014 Aug 20; 126C:55-63. PMID: 25215443. Abstract Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis. Byström S, Ayoglu B, Häggmark A, Mitsios N, Hong M-G, Drobin K, Forsström B, Fredolini C, Khademi M, Amor S, et al. J Proteome Res. 2014 Oct 1. PMID: 25231264. Abstract Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway. Bačić-Baronica K, Mlinac K, Petlevski R, Ozretić D, Vladić A, Kalanj-Bognar S, Zuntar I Acta Neurobiol Exp (Wars). 2014; 74(3):257-65. PMID: 25231845. Abstract The role of iron in brain ageing and neurodegenerative disorders. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L Lancet Neurol. 2014 Oct; 13(10):1045-1060. PMID: 25231526. Abstract Cerebrospinal Fluid Flow Dynamics in Multiple Sclerosis Patients through Phase Contrast Magnetic Resonance Imaging. Lagana M M, Chaudhary A, Balagurunathan D, Utriainen D, Kokeny P, Feng W, Cecconi P, Hubbard D, Haacke M Curr Neurovasc Res. 2014 Aug 29. PMID: 25233279. Abstract Glia in the pathogenesis of neurodegenerative diseases. Verkhratsky A, Parpura V, Pekna M, Pekny M, Sofroniew M Biochem Soc Trans. 2014 Oct 1; 42(5):1291-301. PMID: 25233406. Abstract Association of Viruses in Neurodegenerative and Neurobehavioral Diseases. Karim S, Mirza Z, Kamal MA, Abuzenadah AM, Azhar EI, Al-Qahtani MH, Damanhouri GA, Ahmad F, Sohrab SS CNS Neurol Disord Drug Targets. 2014 Sep 17. PMID: 25230220. Abstract Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment. Eloyan A, Shou H, Shinohara RT, Sweeney EM, Nebel M B, Cuzzocreo JL, Calabresi PA, Reich DS, Lindquist MA, Crainiceanu CM PLoS One. 2014; 9(9):e107263. Epub 2014 Sep 18. PMID: 25233361. Abstract Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial. Rietberg MB, van Wegen EEH, Eyssen ICJM, Kwakkel G, MS study group PLoS One. 2014; 9(9):e107710. Epub 2014 Sep 18. PMID: 25232955. Abstract Olfactory Pathology in Central Nervous System Demyelinating Diseases. Deluca GC, Joseph A, George J, Yates RL, Hamard M, Hofer M, Esiri MM Brain Pathol. 2014 Sep 17. PMID: 25230202. Abstract Vitamin D in allergic disorders. Pawlak J, Doboszyńska A Postepy Hig Med Dosw (Online). 2014; 68:1152-70. PMID: 25228524. Abstract Testicular hypofunction and multiple sclerosis: Cause or consequence? Author's reply. Pakpoor J, Goldacre R, Schmierer K, Giovannoni G, Goldacre MJ Ann Neurol. 2014 Sep 16. PMID: 25228476. Abstract Contribution of symptom clusters to multiple sclerosis consequences. Shahrbanian S, Duquette P, Kuspinar A, Mayo NE Qual Life Res. 2014 Sep 17. Epub 2014 Sep 17. PMID: 25228080. Abstract A Patient Care Program for Adjusting the Autoinjector Needle Depth According to Subcutaneous Tissue Thickness in Patients With Multiple Sclerosis Receiving Subcutaneous Injections of Glatiramer Acetate. Masid M L S, Ocaña R H, Gil M J D, Ramos M C R, Roig M E, Carreño M R C, Morales J C, Carrasco M L V, Hidalgo L M R, Felices A M B, et al. J Neurosci Nurs. 2014 Sep 14. PMID: 25225835. Abstract Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study. Tavazzi E, Laganà M M, Bergsland N, Tortorella P, Pinardi G, Lunetta C, Corbo M, Rovaris M Neurol Sci. 2014 Sep 17. Epub 2014 Sep 17. PMID: 25228014. Abstract Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study. Cambil-Martín J, Galiano-Castillo N, Muñoz-Hellín E, Díaz-Rodríguez L, Laguarta-Val S, Fernández-de-Las-Peñas C, Arroyo-Morales M Nutr Neurosci. 2014 Sep 16. PMID: 25225836. Abstract Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model. Iwasa K, Yamamoto S, Takahashi M, Suzuki S, Yagishita S, Awaji T, Maruyama K, Yoshikawa K Prostaglandins Leukot Essent Fatty Acids. 2014 Sep 6. PMID: 25224839. Abstract Fine-tuning the central nervous system: microglial modelling of cells and synapses. Xavier AL, Menezes JRL, Goldman SA, Nedergaard M Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19; 369(1654). PMID: 25225087. Abstract Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Mao Z, Lu Z, Hu X, Sato D K, Callegaro D, Lana-Peixoto M A, Nakashima I, Fujihara K Neurology. 2014 Sep 16; 83(12):1122-3. PMID: 25224530. Abstract Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity. Kamin F, Rommer P, Abu-Mugheisib M, Koehler W, Hoffmann F, Winkelmann A, Benecke R, Zettl UK Spinal Cord. 2014 Sep 16. PMID: 25224601. Abstract Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy. Sheu J, Kattapuram SV, Stankiewicz JM, Merola JF J Drugs Dermatol. 2014 Sep 1; 13(9):1144-7. PMID: 25226017. Abstract Brain circuitry outside the synaptic cleft. Rusakov DA, Dityatev AE Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19; 369(1654). PMID: 25225085. Abstract Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods. Khan N, Woodruff TM, Smith MT Pharmacol Biochem Behav. 2014 Sep 16; 126C:13-27. PMID: 25223977. Abstract Simvastatin in patients with progressive multiple sclerosis. Giovannoni G, Baker D, Schmierer K Lancet. 2014 Sep 13; 384(9947):952. PMID: 25220965. Abstract Simvastatin in patients with progressive multiple sclerosis--Authors' reply. Chataway J, MS-STAT investigators Lancet. 2014 Sep 13; 384(9947):952-3. PMID: 25220966. Abstract Stem cell therapy for central nerve system injuries: glial cells hold the key. Xiao L, Saiki C, Ide R Neural Regen Res. 2014 Jul 1; 9(13):1253-60. PMID: 25221575. Abstract Adult myelination: wrapping up neuronal plasticity. O'Rourke M, Gasperini R, Young KM Neural Regen Res. 2014 Jul 1; 9(13):1261-4. PMID: 25221576. Abstract Simvastatin in patients with progressive multiple sclerosis. Auer J, Berent R Lancet. 2014 Sep 13; 384(9947):951-2. PMID: 25220964. Abstract Risk stratification and mitigation in multiple sclerosis. Ontaneda D, Cohn S, Fox RJ Mult Scler Relat Disord. 2014 Sep 1; 3(5):639-649. PMID: 25221744. Abstract Strategies for myelin regeneration: lessons learned from development. Bhatt A, Fan L-W, Pang Y Neural Regen Res. 2014 Jul 15; 9(14):1347-50. PMID: 25221590. Abstract Contributing factors in multiple sclerosis and the female sex bias. Khalid R Immunol Lett. 2014 Sep 16. PMID: 25220935. Abstract FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination. Slowik A, Schmidt T, Beyer C, Amor S, Clarner T, Kipp M Br J Pharmacol. 2014 Sep 14. PMID: 25220526. Abstract Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes. McGee J, Minagar A J Neurol Sci. 2014 Sep 6. PMID: 25218415. Abstract Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients. Küçükali C I, Haytural H, Benbir G, Coban A, Ulusoy C, Giriş M, Kürtüncü M, Shugaiv E, Karadeniz D, Tüzün E J Neurol Sci. 2014 Aug 30. PMID: 25218417. Abstract Update on Disease-Modifying Treatments for Multiple Sclerosis. Carrithers MD Clin Ther. 2014 Sep 10. PMID: 25218310. Abstract The role of transcriptional control in multiple system atrophy. Chen J, Mills JD, Halliday GM, Janitz M Neurobiol Aging. 2014 Aug 19. PMID: 25218777. Abstract Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis. Ratzer R, Romme Christensen J, Romme Nielsen B, Sørensen PS, Börnsen L, Sellebjerg F J Neuroimmunol. 2014 Aug 30. PMID: 25218212. Abstract "Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis. Blundell Jones J, Walsh S, Isaac C J Clin Psychol Med Settings. 2014 Sep 14. PMID: 25217970. Abstract Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis. Su N, Shi SX, Zhu X, Borazanci A, Gan Y, Shi F-D J Neuroimmunol. 2014 Aug 27. PMID: 25218211. Abstract Multiple sclerosis: Clinical characteristics and disability progression in Moroccan children. Ait Ben Haddou E, Alhyan M, Aasfara J, Regragui W, Ibrahimi A, Razine R, Abouqal R, Benomar A, Yahyaoui M J Neurol Sci. 2014 Aug 13. PMID: 25216553. Abstract Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI, Mascanfroni ID, Yeste A, Kivisäkk P, Kallas K, et al. Nat Med. 2014 Oct; 20(10):1147-56. Epub 2014 Sep 14. PMID: 25216636. Abstract Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis. Koshihara H, Oguchi K, Takei Y-I, Kitazawa K, Higuchi K, Ohara S J Neurol Sci. 2014 Aug 29. PMID: 25216555. Abstract Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up. Amato MP, Goretti B, Ghezzi A, Hakiki B, Niccolai C, Lori S, Moiola L, Falautano M, Viterbo RG, Patti F, et al. Neurology. 2014 Sep 12. PMID: 25217060. Abstract ALCAM and CD6 - multiple sclerosis risk factors. Wagner M, Bilinska M, Pokryszko-Dragan A, Sobczynski M, Cyrul M, Kusnierczyk P, Jasek M J Neuroimmunol. 2014 Aug 30. PMID: 25216742. Abstract Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis. Erb-Eigner K, Bohner G, Goektas O, Harms L, Holinski F, Schmidt F A, Dahlslett B, Dommes E, Asbach P, Lüdemann L J Neurol Sci. 2014 Aug 29. PMID: 25216554. Abstract Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administration. Othman AA, Tran JQ, Tang MT, Dutta S Clin Pharmacokinet. 2014 Oct; 53(10):907-18. PMID: 25212703. Abstract Multiple sclerosis and vitamin D during pregnancy and lactation. Jalkanen A, Kauko T, Turpeinen U, Hämäläinen E, Airas L Acta Neurol Scand. 2014 Sep 12. PMID: 25216350. Abstract Voiding dysfunction in patients with neuromyelitis optica spectrum disorders. de Carvalho F L, Gomes C M, Apostolos-Pereira SL, Bessa J, Pinheiro M, Marchiori PE, Bruschini H, Srougi M, Callegaro D Neurourol Urodyn. 2014 Sep 11. PMID: 25212666. Abstract ▼Dimethyl fumarate for relapsing-remitting multiple sclerosis. Drug Ther Bull. 2014 Sep; 52(9):105-8. PMID: 25213591. Abstract Picornavirus infection leading to immunosuppression. Cusick MF, Libbey JE, Fujinami RS Future Virol. 2014 May 1; 9(5):475-482. PMID: 25214881. Abstract Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis. Zhang F L, Tossberg JT, Spurlock CF, Yao S-Y, Aune TM, Sriram S Ann Clin Transl Neurol. 2014 May 1; 1(5):307-318. PMID: 25215310. Abstract Glycans of myelin proteins. Sedzik J, Jastrzebski J P, Grandis M J Neurosci Res. 2014 Sep 12. PMID: 25213400. Abstract Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors. Boda E, Di Maria S, Rosa P, Taylor V, Abbracchio MP, Buffo A Glia. 2014 Sep 12. PMID: 25213035. Abstract Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway. Lee S H, Xu G, Jay TR, Bhatta S, Kim K-W, Jung S, Landreth GE, Ransohoff RM, Lamb BT J Neurosci. 2014 Sep 10; 34(37):12538-46. PMID: 25209291. Abstract Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report. Sato H, Kobayashi D, Abe A, Ito S, Ishikawa H, Nakazono K, Murasawa A, Kuroda T, Nakano M, Narita I BMC Res Notes. 2014; 7(1):641. Epub 2014 Sep 12. PMID: 25216562. Abstract Navigating the "liberation procedure": a qualitative study of motivating and hesitating factors among people with multiple sclerosis. Ploughman M, Harris C, Hogan SH, Murray C, Murdoch M, Austin MW, Stefanelli M Patient Prefer Adherence. 2014; 8:1205-13. Epub 2014 Sep 10. PMID: 25228799. Abstract MRI Study: Objective Olfactory Function and CNS Pathologies in Patients with Multiple Sclerosis. Holinski F, Schmidt F, Dahlslett SB, Harms L, Bohner G, Olze H Eur Neurol. 2014 Sep 6; 72(3-4):157-162. Epub 2014 Sep 06. PMID: 25228293. Abstract Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders. Zhao S, Li F, Leak RK, Chen J, Hu X Front Cell Neurosci. 2014; 8:271. Epub 2014 Sep 03. PMID: 25232304. Abstract Whole brain myelin mapping using T1- and T2-weighted MR imaging data. Ganzetti M, Wenderoth N, Mantini D Front Hum Neurosci. 2014; 8:671. Epub 2014 Sep 02. PMID: 25228871. Abstract The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain. Fiebich BL, Akter S, Akundi R S Front Cell Neurosci. 2014; 8:260. Epub 2014 Sep 01. PMID: 25225473. Abstract Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality. Di Battista G, Bertolotto A, Gasperini C, Ghezzi A, Maimone D, Solaro C Mult Scler Int. 2014; 2014:752318. Epub 2014 Aug 26. PMID: 25215236. Abstract [Sympathetic skin response and multiple sclerosis: Descriptive and prospective study, and association with neuroperineal disorders]. Thomas-Pohl M, Weglinski L, Salga M, Blum C, Manceau P, Amarenco G Prog Urol. 2014 Sep; 24(11):691-6. Epub 2014 Aug 22. PMID: 25214450. Abstract Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography. Prasad V P, Wagner S, Keul P, Hermann S, Levkau B, Schäfers M, Haufe G Bioorg Med Chem. 2014 Oct 1; 22(19):5168-81. Epub 2014 Aug 17. PMID: 25216968. Abstract [Physiotherapy and neurogenic lower urinary tract dysfunction in multiple sclerosis patients: A randomized controlled trial]. Gaspard L, Tombal B, Opsomer R-J, Castille Y, van Pesch V, Detrembleur C Prog Urol. 2014 Sep; 24(11):697-707. Epub 2014 Jun 19. PMID: 25214451. Abstract Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration. Vitkova M, Gdovinova Z, Rosenberger J, Szilasiova J, Nagyová I, Mikula P, Krokavcova M, Groothoff JW, van Dijk JP Disabil Health J. 2014 Oct; 7(4):466-71. Epub 2014 Jun 07. PMID: 25224987. Abstract Self-report versus performance measure in gauging level of function with multiple sclerosis. Stuifbergen AK, Morris M, Becker H, Chen L, Lee H Disabil Health J. 2014 Oct; 7(4):413-8. Epub 2014 Apr 24. PMID: 25224981. Abstract Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a. Minciullo PL, Calapai G, Gangemi S Allergy Asthma Immunol Res. 2014 Sep; 6(5):467-9. Epub 2014 Feb 07. PMID: 25229006. Abstract
Editors' Pick Clinical and MRI characterization of MS patients with a pure and severe cognitive onset. Assouad R, Louapre C, Tourbah A, Papeix C, Galanaud D, Lubetzki C, Stankoff B Clin Neurol Neurosurg. 2014 Aug 20; 126C:55-63. PMID: 25215443. Abstract
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis. Byström S, Ayoglu B, Häggmark A, Mitsios N, Hong M-G, Drobin K, Forsström B, Fredolini C, Khademi M, Amor S, et al. J Proteome Res. 2014 Oct 1. PMID: 25231264. Abstract
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway. Bačić-Baronica K, Mlinac K, Petlevski R, Ozretić D, Vladić A, Kalanj-Bognar S, Zuntar I Acta Neurobiol Exp (Wars). 2014; 74(3):257-65. PMID: 25231845. Abstract
The role of iron in brain ageing and neurodegenerative disorders. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L Lancet Neurol. 2014 Oct; 13(10):1045-1060. PMID: 25231526. Abstract
Cerebrospinal Fluid Flow Dynamics in Multiple Sclerosis Patients through Phase Contrast Magnetic Resonance Imaging. Lagana M M, Chaudhary A, Balagurunathan D, Utriainen D, Kokeny P, Feng W, Cecconi P, Hubbard D, Haacke M Curr Neurovasc Res. 2014 Aug 29. PMID: 25233279. Abstract
Glia in the pathogenesis of neurodegenerative diseases. Verkhratsky A, Parpura V, Pekna M, Pekny M, Sofroniew M Biochem Soc Trans. 2014 Oct 1; 42(5):1291-301. PMID: 25233406. Abstract
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases. Karim S, Mirza Z, Kamal MA, Abuzenadah AM, Azhar EI, Al-Qahtani MH, Damanhouri GA, Ahmad F, Sohrab SS CNS Neurol Disord Drug Targets. 2014 Sep 17. PMID: 25230220. Abstract
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment. Eloyan A, Shou H, Shinohara RT, Sweeney EM, Nebel M B, Cuzzocreo JL, Calabresi PA, Reich DS, Lindquist MA, Crainiceanu CM PLoS One. 2014; 9(9):e107263. Epub 2014 Sep 18. PMID: 25233361. Abstract
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial. Rietberg MB, van Wegen EEH, Eyssen ICJM, Kwakkel G, MS study group PLoS One. 2014; 9(9):e107710. Epub 2014 Sep 18. PMID: 25232955. Abstract
Olfactory Pathology in Central Nervous System Demyelinating Diseases. Deluca GC, Joseph A, George J, Yates RL, Hamard M, Hofer M, Esiri MM Brain Pathol. 2014 Sep 17. PMID: 25230202. Abstract
Vitamin D in allergic disorders. Pawlak J, Doboszyńska A Postepy Hig Med Dosw (Online). 2014; 68:1152-70. PMID: 25228524. Abstract
Testicular hypofunction and multiple sclerosis: Cause or consequence? Author's reply. Pakpoor J, Goldacre R, Schmierer K, Giovannoni G, Goldacre MJ Ann Neurol. 2014 Sep 16. PMID: 25228476. Abstract
Contribution of symptom clusters to multiple sclerosis consequences. Shahrbanian S, Duquette P, Kuspinar A, Mayo NE Qual Life Res. 2014 Sep 17. Epub 2014 Sep 17. PMID: 25228080. Abstract
A Patient Care Program for Adjusting the Autoinjector Needle Depth According to Subcutaneous Tissue Thickness in Patients With Multiple Sclerosis Receiving Subcutaneous Injections of Glatiramer Acetate. Masid M L S, Ocaña R H, Gil M J D, Ramos M C R, Roig M E, Carreño M R C, Morales J C, Carrasco M L V, Hidalgo L M R, Felices A M B, et al. J Neurosci Nurs. 2014 Sep 14. PMID: 25225835. Abstract
Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study. Tavazzi E, Laganà M M, Bergsland N, Tortorella P, Pinardi G, Lunetta C, Corbo M, Rovaris M Neurol Sci. 2014 Sep 17. Epub 2014 Sep 17. PMID: 25228014. Abstract
Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study. Cambil-Martín J, Galiano-Castillo N, Muñoz-Hellín E, Díaz-Rodríguez L, Laguarta-Val S, Fernández-de-Las-Peñas C, Arroyo-Morales M Nutr Neurosci. 2014 Sep 16. PMID: 25225836. Abstract
Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model. Iwasa K, Yamamoto S, Takahashi M, Suzuki S, Yagishita S, Awaji T, Maruyama K, Yoshikawa K Prostaglandins Leukot Essent Fatty Acids. 2014 Sep 6. PMID: 25224839. Abstract
Fine-tuning the central nervous system: microglial modelling of cells and synapses. Xavier AL, Menezes JRL, Goldman SA, Nedergaard M Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19; 369(1654). PMID: 25225087. Abstract
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Mao Z, Lu Z, Hu X, Sato D K, Callegaro D, Lana-Peixoto M A, Nakashima I, Fujihara K Neurology. 2014 Sep 16; 83(12):1122-3. PMID: 25224530. Abstract
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity. Kamin F, Rommer P, Abu-Mugheisib M, Koehler W, Hoffmann F, Winkelmann A, Benecke R, Zettl UK Spinal Cord. 2014 Sep 16. PMID: 25224601. Abstract
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy. Sheu J, Kattapuram SV, Stankiewicz JM, Merola JF J Drugs Dermatol. 2014 Sep 1; 13(9):1144-7. PMID: 25226017. Abstract
Brain circuitry outside the synaptic cleft. Rusakov DA, Dityatev AE Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19; 369(1654). PMID: 25225085. Abstract
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods. Khan N, Woodruff TM, Smith MT Pharmacol Biochem Behav. 2014 Sep 16; 126C:13-27. PMID: 25223977. Abstract
Simvastatin in patients with progressive multiple sclerosis. Giovannoni G, Baker D, Schmierer K Lancet. 2014 Sep 13; 384(9947):952. PMID: 25220965. Abstract
Simvastatin in patients with progressive multiple sclerosis--Authors' reply. Chataway J, MS-STAT investigators Lancet. 2014 Sep 13; 384(9947):952-3. PMID: 25220966. Abstract
Stem cell therapy for central nerve system injuries: glial cells hold the key. Xiao L, Saiki C, Ide R Neural Regen Res. 2014 Jul 1; 9(13):1253-60. PMID: 25221575. Abstract
Adult myelination: wrapping up neuronal plasticity. O'Rourke M, Gasperini R, Young KM Neural Regen Res. 2014 Jul 1; 9(13):1261-4. PMID: 25221576. Abstract
Simvastatin in patients with progressive multiple sclerosis. Auer J, Berent R Lancet. 2014 Sep 13; 384(9947):951-2. PMID: 25220964. Abstract
Risk stratification and mitigation in multiple sclerosis. Ontaneda D, Cohn S, Fox RJ Mult Scler Relat Disord. 2014 Sep 1; 3(5):639-649. PMID: 25221744. Abstract
Strategies for myelin regeneration: lessons learned from development. Bhatt A, Fan L-W, Pang Y Neural Regen Res. 2014 Jul 15; 9(14):1347-50. PMID: 25221590. Abstract
Contributing factors in multiple sclerosis and the female sex bias. Khalid R Immunol Lett. 2014 Sep 16. PMID: 25220935. Abstract
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination. Slowik A, Schmidt T, Beyer C, Amor S, Clarner T, Kipp M Br J Pharmacol. 2014 Sep 14. PMID: 25220526. Abstract
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes. McGee J, Minagar A J Neurol Sci. 2014 Sep 6. PMID: 25218415. Abstract
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients. Küçükali C I, Haytural H, Benbir G, Coban A, Ulusoy C, Giriş M, Kürtüncü M, Shugaiv E, Karadeniz D, Tüzün E J Neurol Sci. 2014 Aug 30. PMID: 25218417. Abstract
Update on Disease-Modifying Treatments for Multiple Sclerosis. Carrithers MD Clin Ther. 2014 Sep 10. PMID: 25218310. Abstract
The role of transcriptional control in multiple system atrophy. Chen J, Mills JD, Halliday GM, Janitz M Neurobiol Aging. 2014 Aug 19. PMID: 25218777. Abstract
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis. Ratzer R, Romme Christensen J, Romme Nielsen B, Sørensen PS, Börnsen L, Sellebjerg F J Neuroimmunol. 2014 Aug 30. PMID: 25218212. Abstract
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis. Blundell Jones J, Walsh S, Isaac C J Clin Psychol Med Settings. 2014 Sep 14. PMID: 25217970. Abstract
Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis. Su N, Shi SX, Zhu X, Borazanci A, Gan Y, Shi F-D J Neuroimmunol. 2014 Aug 27. PMID: 25218211. Abstract
Multiple sclerosis: Clinical characteristics and disability progression in Moroccan children. Ait Ben Haddou E, Alhyan M, Aasfara J, Regragui W, Ibrahimi A, Razine R, Abouqal R, Benomar A, Yahyaoui M J Neurol Sci. 2014 Aug 13. PMID: 25216553. Abstract
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI, Mascanfroni ID, Yeste A, Kivisäkk P, Kallas K, et al. Nat Med. 2014 Oct; 20(10):1147-56. Epub 2014 Sep 14. PMID: 25216636. Abstract
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis. Koshihara H, Oguchi K, Takei Y-I, Kitazawa K, Higuchi K, Ohara S J Neurol Sci. 2014 Aug 29. PMID: 25216555. Abstract
Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up. Amato MP, Goretti B, Ghezzi A, Hakiki B, Niccolai C, Lori S, Moiola L, Falautano M, Viterbo RG, Patti F, et al. Neurology. 2014 Sep 12. PMID: 25217060. Abstract
ALCAM and CD6 - multiple sclerosis risk factors. Wagner M, Bilinska M, Pokryszko-Dragan A, Sobczynski M, Cyrul M, Kusnierczyk P, Jasek M J Neuroimmunol. 2014 Aug 30. PMID: 25216742. Abstract
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis. Erb-Eigner K, Bohner G, Goektas O, Harms L, Holinski F, Schmidt F A, Dahlslett B, Dommes E, Asbach P, Lüdemann L J Neurol Sci. 2014 Aug 29. PMID: 25216554. Abstract
Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administration. Othman AA, Tran JQ, Tang MT, Dutta S Clin Pharmacokinet. 2014 Oct; 53(10):907-18. PMID: 25212703. Abstract
Multiple sclerosis and vitamin D during pregnancy and lactation. Jalkanen A, Kauko T, Turpeinen U, Hämäläinen E, Airas L Acta Neurol Scand. 2014 Sep 12. PMID: 25216350. Abstract
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders. de Carvalho F L, Gomes C M, Apostolos-Pereira SL, Bessa J, Pinheiro M, Marchiori PE, Bruschini H, Srougi M, Callegaro D Neurourol Urodyn. 2014 Sep 11. PMID: 25212666. Abstract
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis. Drug Ther Bull. 2014 Sep; 52(9):105-8. PMID: 25213591. Abstract
Picornavirus infection leading to immunosuppression. Cusick MF, Libbey JE, Fujinami RS Future Virol. 2014 May 1; 9(5):475-482. PMID: 25214881. Abstract
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis. Zhang F L, Tossberg JT, Spurlock CF, Yao S-Y, Aune TM, Sriram S Ann Clin Transl Neurol. 2014 May 1; 1(5):307-318. PMID: 25215310. Abstract
Glycans of myelin proteins. Sedzik J, Jastrzebski J P, Grandis M J Neurosci Res. 2014 Sep 12. PMID: 25213400. Abstract
Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors. Boda E, Di Maria S, Rosa P, Taylor V, Abbracchio MP, Buffo A Glia. 2014 Sep 12. PMID: 25213035. Abstract
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway. Lee S H, Xu G, Jay TR, Bhatta S, Kim K-W, Jung S, Landreth GE, Ransohoff RM, Lamb BT J Neurosci. 2014 Sep 10; 34(37):12538-46. PMID: 25209291. Abstract
Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report. Sato H, Kobayashi D, Abe A, Ito S, Ishikawa H, Nakazono K, Murasawa A, Kuroda T, Nakano M, Narita I BMC Res Notes. 2014; 7(1):641. Epub 2014 Sep 12. PMID: 25216562. Abstract
Navigating the "liberation procedure": a qualitative study of motivating and hesitating factors among people with multiple sclerosis. Ploughman M, Harris C, Hogan SH, Murray C, Murdoch M, Austin MW, Stefanelli M Patient Prefer Adherence. 2014; 8:1205-13. Epub 2014 Sep 10. PMID: 25228799. Abstract
MRI Study: Objective Olfactory Function and CNS Pathologies in Patients with Multiple Sclerosis. Holinski F, Schmidt F, Dahlslett SB, Harms L, Bohner G, Olze H Eur Neurol. 2014 Sep 6; 72(3-4):157-162. Epub 2014 Sep 06. PMID: 25228293. Abstract
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders. Zhao S, Li F, Leak RK, Chen J, Hu X Front Cell Neurosci. 2014; 8:271. Epub 2014 Sep 03. PMID: 25232304. Abstract
Whole brain myelin mapping using T1- and T2-weighted MR imaging data. Ganzetti M, Wenderoth N, Mantini D Front Hum Neurosci. 2014; 8:671. Epub 2014 Sep 02. PMID: 25228871. Abstract
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain. Fiebich BL, Akter S, Akundi R S Front Cell Neurosci. 2014; 8:260. Epub 2014 Sep 01. PMID: 25225473. Abstract
Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality. Di Battista G, Bertolotto A, Gasperini C, Ghezzi A, Maimone D, Solaro C Mult Scler Int. 2014; 2014:752318. Epub 2014 Aug 26. PMID: 25215236. Abstract
[Sympathetic skin response and multiple sclerosis: Descriptive and prospective study, and association with neuroperineal disorders]. Thomas-Pohl M, Weglinski L, Salga M, Blum C, Manceau P, Amarenco G Prog Urol. 2014 Sep; 24(11):691-6. Epub 2014 Aug 22. PMID: 25214450. Abstract
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography. Prasad V P, Wagner S, Keul P, Hermann S, Levkau B, Schäfers M, Haufe G Bioorg Med Chem. 2014 Oct 1; 22(19):5168-81. Epub 2014 Aug 17. PMID: 25216968. Abstract
[Physiotherapy and neurogenic lower urinary tract dysfunction in multiple sclerosis patients: A randomized controlled trial]. Gaspard L, Tombal B, Opsomer R-J, Castille Y, van Pesch V, Detrembleur C Prog Urol. 2014 Sep; 24(11):697-707. Epub 2014 Jun 19. PMID: 25214451. Abstract
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration. Vitkova M, Gdovinova Z, Rosenberger J, Szilasiova J, Nagyová I, Mikula P, Krokavcova M, Groothoff JW, van Dijk JP Disabil Health J. 2014 Oct; 7(4):466-71. Epub 2014 Jun 07. PMID: 25224987. Abstract
Self-report versus performance measure in gauging level of function with multiple sclerosis. Stuifbergen AK, Morris M, Becker H, Chen L, Lee H Disabil Health J. 2014 Oct; 7(4):413-8. Epub 2014 Apr 24. PMID: 25224981. Abstract
Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a. Minciullo PL, Calapai G, Gangemi S Allergy Asthma Immunol Res. 2014 Sep; 6(5):467-9. Epub 2014 Feb 07. PMID: 25229006. Abstract